Patents by Inventor Daniel Milfred Bernstein
Daniel Milfred Bernstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230317276Abstract: Method and apparatus including calling, retrieving and/or initiating a programmed function in conjunction with execution of one or more commands related to a closed loop control algorithm, receiving one or more data in response to the one or more commands over a data interface, and executing the one or more commands related to the closed loop control algorithm based on the received one or more data are provided.Type: ApplicationFiled: April 3, 2023Publication date: October 5, 2023Applicant: Abbott Diabetes Care Inc.Inventors: Marc Barry TAUB, Daniel Milfred BERNSTEIN, Gary Alan HAYTER, Mark Kent SLOAN, Glenn Howard BERMAN, Saeed NEKOOMARAM
-
Publication number: 20230268071Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.Type: ApplicationFiled: February 28, 2023Publication date: August 24, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Publication number: 20230238131Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.Type: ApplicationFiled: April 3, 2023Publication date: July 27, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Publication number: 20230200687Abstract: Methods, devices and system for determining fasting glucose level information and post-prandial glucose level information for diagnosing pre-diabetic and diabetic conditions based on monitored glucose measurements are provided.Type: ApplicationFiled: March 6, 2023Publication date: June 29, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Gary Alan Hayter, Daniel Milfred Bernstein, Erwin Satrya Budiman
-
Publication number: 20230157643Abstract: Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.Type: ApplicationFiled: January 6, 2023Publication date: May 25, 2023Applicant: ABBOTT DIABETES CARE INC.Inventors: Gary Alan Hayter, Nathan Christopher Crouther, Michael Love, Erwin Satrya Budiman, Daniel Milfred Bernstein
-
Patent number: 11621073Abstract: A method of providing treatment for a medical condition includes storing a plurality of closed loop control algorithms in memory accessible by the control unit and receiving. A control unit receives analyte data from an analyte sensor in communication with the control unit. The control unit controls a medication delivery device in accordance with the first closed loop control algorithm based on the analyte data. The control unit causes the medication delivery device to be controlled in accordance with the second closed loop control algorithm instead of the first closed loop control algorithm, and controlling the medication delivery device in accordance with the second closed loop control algorithm. The control unit is configured to transmit one or more closed loop control operations to control the medication delivery device.Type: GrantFiled: June 25, 2019Date of Patent: April 4, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Marc Barry Taub, Daniel Milfred Bernstein, Gary Alan Hayter, Mark Kent Sloan, Glenn Howard Berman, Saeed Nekoomaram
-
Patent number: 11596330Abstract: Methods, devices and system for determining fasting glucose level information and post-prandial glucose level information for diagnosing pre-diabetic and diabetic conditions based on monitored glucose measurements are provided.Type: GrantFiled: March 20, 2018Date of Patent: March 7, 2023Assignee: ABBOTT DIABETES CARE INC.Inventors: Gary Alan Hayter, Daniel Milfred Bernstein, Erwin Satrya Budiman
-
Patent number: 11553883Abstract: Method, device and system for providing consistent and reliable glucose response information to physiological changes and/or activities is provided to improve glycemic control and health management.Type: GrantFiled: July 8, 2016Date of Patent: January 17, 2023Assignee: Abbott Diabetes Care Inc.Inventors: Gary Alan Hayter, Nathan Christopher Crouther, Michael Love, Erwin Satrya Budiman, Daniel Milfred Bernstein
-
Publication number: 20220359074Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user. The in vivo analyte sensor is coupled to an electronics unit holding a memory with instruction to cause processing circuitry to initiate a predetermined time period that is longer than a predetermined life of the sensor, during the predetermined time period, convert signals from the sensor related to glucose to respective corresponding glucose levels, without relying on any post-manufacture independent analyte measurements from a reference device, and at the expiration of the predetermined time period, disable, deactivate, or cease use of one or more feature.Type: ApplicationFiled: July 14, 2022Publication date: November 10, 2022Applicant: ABBOTT DIABETES CARE INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Publication number: 20220181022Abstract: Methods and devices and systems include generating analyte data based on signals from an analyte sensor transcutaneously positioned in contact with interstitial fluid under a skin layer of a user and to generate signals corresponding to an analyte level of a target analyte. The analyte data corresponds to the analyte level of the target analyte over a wear period. Methods include storing the analyte data over the wear period. Methods include determining one or more indications based on the analyte data. Methods include determining a reimbursement insurance code based at least in part on stored sensor information associated with the analyte sensor. Methods include communicating at least a portion of the analyte data and the reimbursement insurance code to an electronic record associated with the user and stored by a remote electronic medical record system. Methods include providing the one or more indications on a user interface unit.Type: ApplicationFiled: February 22, 2022Publication date: June 9, 2022Applicant: Abbott Diabetes Care Inc.Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
-
Patent number: 11276492Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.Type: GrantFiled: September 11, 2020Date of Patent: March 15, 2022Assignee: Abbott Diabetes Care Inc.Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
-
Patent number: 11264133Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.Type: GrantFiled: January 25, 2021Date of Patent: March 1, 2022Assignee: Abbott Diabetes Care Inc.Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
-
Publication number: 20210322676Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an adverse condition associated with the monitored physiological condition or the medication administration deviating from a predetermined safety level of the closed loop control operation, and initiating a non-zero pre-programmed medication delivery rate are provided.Type: ApplicationFiled: June 29, 2021Publication date: October 21, 2021Applicant: Abbott Diabetes Care Inc.Inventors: Gary Alan Hayter, Marc Barry Taub, Daniel Milfred Bernstein, Mark Kent Sloan
-
Patent number: 11083843Abstract: Methods, system and devices for monitoring a plurality of parameters associated with a closed loop control operation including continuously monitoring a physiological condition and automatic administration of a medication, detecting an adverse condition associated with the monitored physiological condition or the medication administration deviating from a predetermined safety level of the closed loop control operation, and initiating a non-zero pre-programmed medication delivery rate are provided.Type: GrantFiled: August 14, 2018Date of Patent: August 10, 2021Assignee: Abbott Diabetes Care Inc.Inventors: Gary Alan Hayter, Marc Barry Taub, Daniel Milfred Bernstein, Mark Kent Sloan
-
Publication number: 20210151182Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.Type: ApplicationFiled: January 25, 2021Publication date: May 20, 2021Applicant: Abbott Diabetes Care Inc.Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
-
Publication number: 20210000396Abstract: Methods and devices and systems including a communication module operatively coupled to a data collection module for communicating the stored analyte related data after the analyte related data is stored in the data collection module over a predetermined time period, and a user interface unit configured to communicate with the communication module to receive from the communication module the stored analyte related data in the data collection module over the predetermined time period, and to output information associated with the monitored analyte level, where the user interface unit is configured to operate in a prospective analysis mode including substantially real time output of information associated with the monitored analyte level, or a retrospective analysis mode including limited output of information during the predetermined time period wherein no information related to the monitored analyte level is output during the predetermined time period, are provided.Type: ApplicationFiled: September 11, 2020Publication date: January 7, 2021Applicant: Abbott Diabetes Care Inc.Inventors: Daniel Milfred Bernstein, Jared Watkin, Martin J. Fennell, Mark Kent Sloan, Michael Love, Namvar Kiaie, Jean-Pierre Cole, Steve Scott
-
Publication number: 20200100676Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.Type: ApplicationFiled: December 2, 2019Publication date: April 2, 2020Applicant: Abbott Diabetes Care Inc.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Publication number: 20190381244Abstract: Method and apparatus including calling, retrieving and/or initiating a programmed function in conjunction with execution of one or more commands related to a closed loop control algorithm, receiving one or more data in response to the one or more commands over a data interface, and executing the one or more commands related to the closed loop control algorithm based on the received one or more data are provided.Type: ApplicationFiled: June 25, 2019Publication date: December 19, 2019Applicant: Abbott Diabetes Care Inc.Inventors: Marc Barry Taub, Daniel Milfred Bernstein, Gary Alan Hayter, Mark Kent Sloan, Glenn Howard Berman, Saeed Nekoomaram
-
Patent number: 10492685Abstract: Methods and devices to monitor an analyte in body fluid are provided. Embodiments include continuous or discrete acquisition of analyte related data from a transcutaneously positioned in vivo analyte sensor automatically or upon request from a user.Type: GrantFiled: August 31, 2015Date of Patent: December 3, 2019Assignee: Abbott Diabetes Care Inc.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Michael Love, Lei He, Christopher Allen Thomas, Udo Hoss, Benjamin Jay Feldman, Kenneth J. Doniger, Gary Ashley Stafford, Gary Alan Hayter, Phillip Yee, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub, Louis George Pace, Jeffery Mario Sicurello
-
Patent number: D962446Type: GrantFiled: April 1, 2021Date of Patent: August 30, 2022Assignee: ABBOTT DIABETES CARE, INC.Inventors: Daniel Milfred Bernstein, Martin J. Fennell, Mark Kent Sloan, Lei He, Gary Alan Hayter, Namvar Kiaie, Jean-Pierre Cole, Marc Barry Taub